Skip to main content

Mycelex Troche Side Effects

Generic name: clotrimazole

Medically reviewed by Drugs.com. Last updated on Jul 4, 2024.

Note: This document provides detailed information about Mycelex Troche Side Effects associated with clotrimazole. Some dosage forms listed on this page may not apply specifically to the brand name Mycelex Troche.

Applies to clotrimazole: lozenge/troche.

Common side effects of Mycelex Troche

Some side effects of clotrimazole may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common side effects

Note: Some of the side effects, such as abdominal or stomach cramping or pain or diarrhea, usually occur only when the medicine is swallowed

Serious side effects of Mycelex Troche

Along with its needed effects, clotrimazole (the active ingredient contained in Mycelex Troche) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

For healthcare professionals

Applies to clotrimazole: oral lozenge, topical cream, topical lotion, topical powder, topical solution, vaginal cream with applicator, vaginal kit, vaginal tablet.

Hepatic adverse events

Gastrointestinal

Dermatologic

References

1. (2001) "Product Information. Mycelex (clotrimazole)." Bayer

Frequently asked questions

Further information

Mycelex Troche side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.